# (1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis

> **NCT02734550** · NA · COMPLETED · sponsor: **Center for Sepsis Control and Care, Germany** · enrollment: 342 (actual)

## Conditions studied

- Severe Sepsis
- Septic Shock

## Interventions

- **OTHER:** Standard of care
- **OTHER:** (1,3)-β-D-glucan guided therapy

## Key facts

- **NCT ID:** NCT02734550
- **Lead sponsor:** Center for Sepsis Control and Care, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-12
- **Primary completion:** 2019-08-22
- **Final completion:** 2019-09-17
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2022-08-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02734550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02734550, "(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02734550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*